Electronic cigarettes and vaping: A new challenge in clinical medicine and public health. A literature review

Frontiers in Public Health

Volumn 1, Issue NOV, 2013, Pages

  Palazzolo, Dominic L ^a  

^a Lincoln Memorial University   (United States)

Author keywords

Electronic cigarettes; Harm reduction; Nicotine addiction; Nicotine replacement; Smoking cessation; Vaping

Indexed keywords

EID: 84941881425     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2013.00056     Document Type: Article

References (124)

1. Modi N, Schmid B, Miller R. Clearing the Smoke on e-Cigarettes. New York, NY: UBS Securities LLC (2012). Available from: http://www.stevevape.com/ wp-content/uploads/2012/05/Clearing-the-Smoke-on-E-Cigarettes.pdf
2. Woodcock J. Letter to Mr. Matt Salmon, President, Electronic Cigarette Association. (2013). Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/UCM225263.pdf
3. Electronic Cigarette Consumer Reviews (ECCR). ECCR. (2013). Available from: http://www.electroniccigaretteconsumerreviews.com/about-us
4. Westenberger BJ. Evaluation of e-Cigarettes. St. Louis, MO: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis (2009). Available from: http://www.fda.gov/downloads/drugs/Scienceresearch/ UCM173250.pdf
5. Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 Fed-eral Food, Drug and Cosmetic Act as Amended through 2013, Pub L No 113-5, 127 Stat 161 (2013). Available from: http://www.gpo.gov/fdsys/pkg/ PLAW113publ5/pdf/PLAW-113publ5.pdf
6. Smoking Everywhere, Inc. v. U.S. Food and Drug Administration and U.S. Department of Health and Human Services, 1:09-cv-00771-RJL (D DC 2009). Available from: http://www.fdalawblog.net/files/smoking-everywhere-tro.pdf
7. Sottera Inc., Doing Business as NJOY v. Food and Drug Administra-tion, et al. (DC Cir 2010). Available from: http://www.cadc.uscourts. gov/internet/opinions.nsf/D02F9D2CA50299F0852577F20070BCC2/file/ 10-5032-1281606.pdf
8. U.S. FDA. Electronic cigarettes (e-cigarettes). News Events. (2013). Available from: http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm172906.htm
9. Laugesen M. Safety Report on the Ruyan® e-Cigarette and Inhaled Aerosol. Christchurch: Health New Zealand Ltd (2008). Available from: http://www. healthnz.co.nz/RuyanCartridgeReport30-Oct-08.pdf
10. Cahn Z,Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: astep forward or a repeat of past mistakes? J Public Health Policy (2011) 32:16-31. doi:10.1057/jphp.2010.41
11. McAuley TR, Hopke PK, Zhao J, Babaian S. Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol (2012) 24:850-7. doi:10.3109/08958378.2012.724728
12. Foulds J, Veldheer S, Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract (2011) 65:1037-42. doi:10.1111/j.1742-1241.2011.02751.x
13. Foulds J, Veldheer S. Commentary on Etter & Bullen (2011): could e-cigs become the ultimate nicotine maintenance device? Addiction (2011) 106:2029-30. doi:10.1111/j.1360-0443.2011.03532.x
14. Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act of 2009, Pub L No 111-31, 113 Stat 1776 (2009). Available from: http://www.gpo.gov/fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf
15. Council on Science and Public Health (CSAPH), American Medical Association. Use of electronic cigarettes in smoking cessation programs. Report 6 (A-10), 159th Annual Meeting. Chicago, IL: American Medical Association House of Delegates. Available from: http://www.ama-assn.org//resources/doc/csaph/ a10csaph6ft.pdf
16. Piano MR, Benowitz NL, Fitzgerald GA, Corbridge S, Heath J, Hahn E, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation (2010) 122:1520-44. doi:10.1161/CIR. 0b013e3181f432c3
17. Avdalovic MV,MurinS.Electronic cigarettes:nosuch thingasafree lunchr puff. Chest (2012) 141:1371-2. doi:10.1378/chest.12-0205
18. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the'e-cigarette'in the USA.Tob Control (2013) 22:19-23. doi:10.1136/tobaccocontrol-2011-050044
19. KralikovaE,KubatovaS,TruneckovaK,KmetovaA,HajekP.The electronic cig-arette: what proportion of smokers have tried it and how many use it regularly? Addiction (2012) 107:1528-9. doi:10.1111/j.1360-0443.2012.03916.x
20. Kralikova E, Novak J, West O, Kmetova A, Hajek P. Do e-cigarettes have the potential to compete with conventional cigarettes? A survey of conventional cigarette smokers' experiences with e-cigarettes. Chest (2013) 144:1609-14. doi:10.1378/chest.12-2842
21. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health (2010) 10:231. doi:10.1186/1471-2458-10-231
22. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction (2011) 106:2017-28. doi:10.1111/j.1360-0443. 2011.03505.x
23. Dawkins L, Turner J, Roberts A, Soar K. 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction (2013) 108:1115-25. doi:10.1111/add.12150
24. Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in great britain. Nicotine Tob Res (2013) 15:1737-44. doi:10.1093/ntr/ ntt057
25. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse (2013) 7:139-46. doi:10.4137/SART.S12756
26. Barbeau AM, BurdaJ,Siegel M.Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract (2013) 8:5. doi:10.1186/1940-0640-8-5
27. Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an Internet survey. Drug Alcohol Re v (2013) 32:133-40. doi:10.1111/j.1465-3362.2012.00512.x
28. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health (2011) 11:786. doi:10.1186/1471-2458-11-786
29. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med (2013). doi:10.1007/ s11739-013-0977-z
30. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of aneLectronic cigAreTte (ECLAT)astobacco cigarettes substitute:a prospective 12-monthrandomized control designstudy.PLoS One (2013) 8:e66317. doi:10.1371/journal.pone.0066317
31. Caponnetto P,Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health (2013) 10:446-61. doi:10.3390/ijerph10020446
32. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res (2013) 15:1787-91. doi:10.1093/ntr/ntt061
33. Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res (2013) 15:e59. doi:10.2196/jmir.2324
34. Pokhrel P, Fagan P, Little MA, Kawamoto CT, Herzog TA. Smokers who try e-cigarettes to quit smoking: findings from a multiethnic study in Hawaii. Am J Public Health (2013) 103:e57-62. doi:10.2105/AJPH.2013.301453
35. Sutfin EL, McCoy TP, Morrell HE, Hoeppner BB, Wolfson M. Electronic cigarette use by college students. Drug Alcohol Depend (2013) 131:214-21. doi:10.1016/j.drugalcdep.2013.05.001
36. Cho JH, Shin E, Moon SS. Electronic-cigarette smoking experience among adolescents. J Adolesc Health (2011) 49:542-6. doi:10.1016/j.jadohealth.2011. 08.001
37. Pepper JK, Reiter PL, McReeAL, Cameron LD, Gilkey MB, Brewer NT. Adolescent males' awareness of and willingness to try electronic cigarettes. J Adolesc Health (2013) 52:144-50. doi:10.1016/j.jadohealth.2012.09.014
38. Choi K, Fabian L, Mottey N, Corbett A, Forster J. Young adults' favorable perceptions of snus, dissolvable tobacco products, and electronic cigarettes: findings from a focus group study. Am J Public Health (2012) 102:2088-93. doi:10.2105/AJPH.2011.300525
39. Choi K, Forster J. Characteristics associated with awareness, percep-tions, and use of electronic nicotine delivery systems among young US Midwestern adults. Am J Public Health (2013) 103:556-61. doi:10.2105/AJPH. 2012.300947
40. Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among teenagers and young adults in Poland. Pediatrics (2012) 130:e879-85. doi:10.1542/peds. 2011-3448
41. Hughes JR, Shiffman S, Callas P, Zhang J. A meta-analysis of the effi-cacy of over-the-counter nicotine replacement. Tob Control (2003) 12:21-7. doi:10.1136/tc.12.1.21
42. Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, et al. Efficacy of the nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine Tob Res (2006) 8:555-64. doi:10.1080/ 14622200600789916
43. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2012) 11:CD000146. doi:10.1002/14651858.CD000146.pub4
44. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction (2004) 99:29-38. doi:10.1111/j. 1360-0443.2004.00540.x
45. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. Am J Prev Med (2011) 40:472-5. doi:10. 1016/j.amepre.2010.12.006
46. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet (2013). doi:10.1016/S0140-6736(13)61842-5
47. Li J, Bullen C, Newcombe R, Walker N, Walton D. The use and acceptability of electronic cigarettes among New Zealand smokers. N Z Med J (2013) 126:48-57.
48. Cobb NK, Abrams DB. E-cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med (2011) 365:193-5. doi:10.1056/ NEJMp1105249
49. Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health (2011) 8:613-28. doi:10.3390/ijerph8020613
50. Williams M,Villarreal A, Bozhilov K, Lin S,Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One (2013) 8:3. doi:10.1371/journal.pone.0057987
51. Stepanov I, Jensen J, Hatsukami D, Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res (2006) 8:309-13. doi:10.1080/ 14622200500490151
52. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res (2013) 15:158-66. doi:10.1093/ntr/ nts103
53. Goniewicz ML,KnysakJ,GawronM,KosmiderL,SobczakA,KurekJ,et al. Lev-els of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control (2013). doi:10.1136/tobaccocontrol-2012-050859
54. Schripp T, Markewitz D, Thornley S, Glover M, Laugesen M. Does e-cigarette consumption cause passive vaping? Indoor Air (2013) 23:25-31. doi:10.1111/j.1600-0668.2012.00792.x
55. Kim HJ, Shin HS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A (2013) 1291:48-55. doi:10.1016/j.chroma.2013. 03.035
56. Pellegrino RM, Tinghino B, Mangiaracina G, Marani A, Vitali M, Protano C, et al. Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig (2012) 24:279-88.
57. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B. Iden-tification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A (2010) 1217:7547-55. doi:10.1016/j.chroma.2010.10.018
58. Moorea TW, Allgirea JF, Woodruffa JT, Ahadia SS, Blacka JC, Westenberger BJ. Analysis of electronic cigarette Cartridges, refill solutions and smoke from nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol (2011) 34:1442-58. doi:10.1080/10826076.2011.572213
59. Bullen C, McRobbie H, Thornley S, Glover M, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control (2010) 19:98-103. doi:10.1136/tc.2009.031567
60. Cheah NP, Chong NW, Tan J, Morsed FA, Yee SK. Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective. Tob Control (2012). doi:10.1136/tobaccocontrol-2012-050483
61. Flouris AD, Oikonomou DN. Electronic cigarettes: miracle or menace? BMJ (2010) 340:c311. doi:10.1136/bmj.c311
62. Cameron JM,Howell DN,White JR,Andrenyak DM, Layton ME,Roll JM.Vari-able and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control (2013). doi:10.1136/tobaccocontrol-2012-050604
63. Etter JF, Zäther E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction (2013) 108:1671-9. doi:10.1111/add.12235
64. Chu VL. Nicotine replacement therapy for tobacco use cessation: reference table. J Pharm Pract (2006) 19:297-300. doi:10.1177/0897190007300456
65. Trtchounian A, Talbot P. Electronic nicotine delivery systems: is there a need for regulation? Tob Control (2011) 20:47-52. doi:10.1136/tc.2010.037259
66. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control (2010) 19:87-8. doi:10.1136/tc.2009.033498
67. VansickelAR,Cobb CO,Weaver MF,Eissenberg TE.Aclinical laboratorymodel for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev (2010) 19:1945-53. doi:10.1158/1055-9965.EPI-10-0288
68. Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the phar-macotherapy of smoking. JAMA (1999) 281:72-6. doi:10.1001/jama.281.1.72
69. Anczak JD, NoglerRA II. Tobacco cessation in primarycare: maximizing intervention strategies. Clin Med Res (2003) 1:201-16. doi:10.3121/cmr.1.3.201
70. Lunell E, Molander L, Ekberg K, Wahren J. Site of nicotine absorption from a vapour inhaler - comparison with cigarette smoking. Eur J Clin Pharmacol (2000) 55:737-41. doi:10.1007/s002280050007
71. Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis DM. Advances in pharmacotherapy for tobacco dependence. Expert Opin Emerg Drugs (2004) 9:39-53. doi:10.1517/14728214.9.1.39
72. Sahu SK, Tiwari M, Bhangare RC, Pandit GG. Particle size distributions of mainstream and exhaled cigarette smoke and predictive deposition in human respiratory tract. Aerosol Air Qual Res (2013) 13:324-32.
73. Zhang Y, Sumner W, Chen DR. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res (2012) 15:501-8. doi:10.1093/ntr/nts165
74. Ingebrethsen BJ, Cole SK, Alderman SL. Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol (2012) 24:976-84. doi:10.3109/ 08958378.2012.744781
75. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res (2013) 15:267-70. doi:10.1093/ ntr/ntr316
76. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) (2013). doi:10.1007/s00213-013-3249-8
77. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction (2012) 107:1493-500. doi:10.1111/j.1360-0443.2012.03791.x
78. Etter JF, Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur Respir J (2011) 38:1219-20. doi:10.1183/09031936.00066011
79. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol (2013) 25:91-101. doi:10.3109/08958378.2012.758197
80. Benowitz NL, Hansson A, Jacob P III. Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension (2002) 39:1107-12. doi:10.1161/01.HYP.0000018825.76673.EA
81. Najem B, Houssière A, Pathak A, Janssen C, Lemogoum D, Xhaët O, et al. Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension (2006) 47:1162-7. doi:10.1161/01.HYP.0000219284.47970.34
82. Czogala J,Cholewinski M, Kutek A, Zielinska-Danch W. Evaluation of changes in hemodynamic parameters after the use of electronic nicotine delivery systems among regular cigarette smokers. Przegl Lek (2012) 69:841-5.
83. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health (2013) 10:2500-14. doi:10.3390/ijerph10062500
84. Trtchounian A, Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res (2010) 12:905-12. doi:10.1093/ntr/ntq114
85. Hua M, Yip H, Talbot P. Mining data on usage of electronic nicotine deliv-ery systems (ENDS) from YouTube videos. J Med Internet Res (2013) 15:e59. doi:10.1136/tobaccocontrol-2011-050226
86. Williams M, Talbot P. Variability among electronic cigarettes in the pressure drop,airflow rate,and aerosol production.Nicotine Tob Res (2011) 13:1276-83. doi:10.1093/ntr/ntr164
87. Sherwood N. Effects of nicotine on human pschomotor performance. Hum Psychopharmacol (1993) 8:155-84. doi:10.1002/hup.470080302
88. Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) (2010) 210:453-69. doi:10.1007/s00213-010-1848-1
89. Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull (1996) 52:58-73. doi:10.1093/ oxfordjournals.bmb.a011533
90. Dawkins L, Turner J, Crowe E. Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers. Psychophar-macology (Berl) (2013) 227:377-84. doi:10.1007/s00213-013-2983-2
91. Dawkins L, Turner J,Hasna S, Soar K. The electronic-cigarette: effects on desire to smoke,withdrawalsymptoms and cognition.Addict Behav (2012) 37:970-3. doi:10.1016/j.addbeh.2012.03.004
92. Evans DE, Drobes DJ. Nicotine self-medication of cognitive-attentional processing. Addict Bio (2009) 14:32-42. doi:10.1111/j.1369-1600.2008.00130.x
93. Laviolette SR, van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci (2004) 5:55-65. doi:10.1038/nrn1298
94. Lewis A, Miller JH, Lea RA. Monoamine oxidase and tobacco dependence. Neurotoxicology (2007) 28:182-95. doi:10.1016/j.neuro.2006.05.019
95. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, et al. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 93:14065-9. doi:10.1073/pnas.93.24.14065
96. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 379:733-6. doi:10.1038/379733a0
97. Casella G, Caponnetto P, Polosa R. Therapeutic advances in the treatment of nicotine addiction: present and future. Ther Adv Chronic Dis (2010) 1:95-106. doi:10.1177/2040622310374896
98. Gross J, Stitzer ML. Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology (Berl) (1989) 98:334-41. doi:10.1007/ BF00451684
99. McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest (2012) 141:1110-3. doi:10.1378/chest.11-1334
100. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest (2012) 141:1400-6. doi:10.1378/chest.11-2443
101. Hansson L, Choudry NB, Karlsson JA, Fuller RW. Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. J Appl Physiol (1994) 76:2420-7.
102. Smith AD, Taylor DR. Is exhaled nitric oxide measurement a useful clinical test in asthma? Curr Opin Allergy Clin Immunol (2005) 5:49-56. doi:10.1097/ 00130832-200502000-00010
103. JatakanonA,Lim S,Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax (1998) 53:91-5. doi:10.1136/thx.53.2.91
104. TaylorDR,Pijnenburg MW,SmithAD,deJongste JC. Exhaled nitricoxide measurements: clinical application and interpretation. Thorax (2006) 61:817-27. doi:10.1136/thx.2005.056093
105. Taylor DR, Mandhane P, Greene JM, Hancox RJ, Filsell S, McLachlan CR, et al. Factors affecting exhaled nitric oxide measurements: the effect of sex. Respir Res (2007) 8:82. doi:10.1186/1465-9921-8-82
106. Karrasch S, Ernst K, Behr J, Heinrich J, Huber RM, Nowak D, et al. Exhaled nitric oxide and influencing factors in a random population sample. Respir Med (2011) 105:713-8. doi:10.1016/j.rmed.2010.11.002
107. Malinovschi A, Janson C, Holmkvist T, Norback D, Merilainen P, Hogman M. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J (2006) 28:339-45. doi:10.1183/09031936. 06.00113705
108. Habib SS, Ahmed SM, Al Drees AM, Husain A. Effect of cigarette smoking on fractional exhaled nitric oxide in Saudi medical college students. J Pak Med Assoc (2011) 61:120-3.
109. Yoda Y, Otani N, Hasunuma H, Kanegae H, Shima M. Storage conditions for stability of offline measurement of fractional exhaled nitric oxide after collection for epidemiologic research. BMC Pulm Med (2012) 12:68. doi:10.1186/1471-2466-12-68
110. Robbins RA, Millatmal T, Lassi K, Rennard S, Daughton D. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest (1997) 112:313-8. doi:10.1378/chest.112.2.313
111. McMillan K, Bredt DS, Hirsch DJ, Snyder SH, Clark JE, Masters BS. Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc Natl Acad Sci U S A (1992) 89:11141-5. doi:10.1073/pnas.89.23.11141
112. Johnson FK, Johnson RA. Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles. Am J Physiol Regul Integr Comp Physiol (2003) 285:R536-41.
113. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Reports (2011) 5:585-90. doi:10.1186/1752-1947-5-585
114. Chambers DC, Tunnicliffe WS, Ayres JG. Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax (1998) 53:677-9. doi:10.1136/thx.53.8.677
115. Buda K, Kulinska K, Billert H. Acute smoking effect in respect to exhaled nitric oxide - a preliminary report. Przegl Lek (2011) 68:738-41.
116. Wieslander G, Norback D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med (2001) 58:649-55. doi:10.1136/oem.58.10.649
117. Choi H, Schmidbauer N, Sundell J, Hasselgren M, Spengler J, Bornehag C. Common household chemicals and the allergy risks in pre-school age children. PLoS One (2010) 5:e13423. doi:10.1371/journal.pone.0013423
118. Robertson OH, Loosli CG, Puck TT, Wise H, Lemon HM, Lester W. Tests for the chronic toxicity of propylene glycol and triethylene glycol on monkeys and rats by vapor inhalation and oral administration. J Pharmacol Exp Ther (1947) 91:52-76.
119. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol (2012) 34:529-37. doi:10.1016/j.reprotox.2012.08.001
120. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol (2013) 25:354-61. doi:10.3109/08958378. 2013.793439
121. Flouris AD, Poulianiti KP, Chorti AZ, Jamurtas MS, Kouretas D, Owolabi EO, et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol (2012) 50:3600-3. doi:10.1016/j.fct.2012.07. 025
122. Bridges AB, Hill A,Belch JJ. Cigarette smoking increases white blood cell aggre-gation in whole blood. J R Soc Med (1993) 86:139-40.
123. Farsalinos KE, Romagna G. Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clin Med Insights Case Rep (2013) 6:15-21. doi:10.4137/CCRep. S11175
124. Noel J, Rees VW, Connolly GN. Electronic cigarettes: a new 'tobacco' industry? Tob Control (2011) 20:81. doi:10.1136/tc.2010.038562